Navigation Links
Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
Date:9/27/2007

ST. LOUIS, Sept. 27 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) is pleased to announce that Patrick M. Sullivan has been named the Vice President of R&D for the Research Biotech business unit, effective October 1, 2007. In this role, he will help expand Sigma-Aldrich's leadership position through the development of new and innovative products for life science researchers. Sullivan has been involved with Sigma-Aldrich since 2005 as a member of the Company's Scientific Advisory Board, where he provided a large pharmaceutical perspective on new strategic plans and product offerings in the Company's Research Biotech business unit. Sullivan will report directly to David A. Smoller, Ph.D., President of Research Biotech.

Pat Sullivan has over 19 years of experience using and developing genomic-based solutions for the pharmaceutical and biotech industries. He was employed by Monsanto/Searle/Pharmacia for 12 years, where he provided molecular biology support for Inflammation and angiogenesis new target/biomarker discovery projects. He joined Incyte Genomics in 2000 as the Vice President of Global Operations, responsible for managing all genomic products and services. Most recently, Sullivan was employed by Pfizer, where he led efforts to identify new therapeutic opportunities in osteoarthritis and cardiovascular diseases.

"We are pleased to have such an strong and experienced leader join our organization," said David A. Smoller. "Patrick's combination of technical expertise, strong ability to analyze complex business operations and implement strategies to improve performance will be an immediate asset to our Research Biotech business unit's mission of bringing innovative technologies and solutions to life science researchers. We look forward to having him join us in making these valuable contributions to our life science community."

Sullivan received his B.S. degree in Microbiology from Western Illinois University and his M.S. degree in Mo
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Wisconsin IT association names Gee president, CEO
2. Quintessence Biosciences names new president
3. CDW names VP to handle Berbee merger
4. NimbleGen names CFO with capital-raising past
5. Cisco names Berbee a top partner of 2005
6. Cisco names Inacom most innovative partner
7. UW-Madison medical school names new dean
8. GE Healthcare names new CEO
9. Bruker AXS names new leadership
10. Sonic Foundry names new senior vice president
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
(Date:7/29/2015)... ... July 29, 2015 , ... Available in ... Express Contouring Bi-Gel, a nighttime-specific product that targets fat cells for extreme contouring ... able to enter fat cells, inhibiting the formation of new fat. Upon waking ...
(Date:7/29/2015)... ... 29, 2015 , ... Asymmetrex, LLC founder and ... the full range of capabilities of its unique cache of technologies for identifying, ... day-to-day renewal and repair of normal tissues and organs. This property makes them ...
(Date:7/28/2015)... ... July 29, 2015 , ... Strong Animals™ announced today that research conducted ... and presented at the ADSA-ASAS Joint Annual Meeting held July 12-16 in Orlando, FL ... and increased milk fat content. Also, feed containing Stay Strong™ for Dairy Cows took ...
Breaking Biology Technology:Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4Strong Animals™ Announces South Dakota State University Research Demonstrates Stay Strong™ for Dairy Cows Improves Performance and Feed Stability 2
... WEST LAFAYETTE, Ind. - Researchers have developed a ... "biosensors," a tool that could help industry perfect ... to environmental monitoring. , The experimental devices represent ... capture and detect specific "target molecules," which will ...
... the Board ... Neill Named President, ISELIN, N.J., Jan. 3 Pharmos Corporation,(Nasdaq: ... effective immediately., Board Changes, Robert F. Johnston has been elected ... and Mony Ben Dor have retired from,the Board., The Pharmos Board ...
... Jan. 3 Danaher Corporation (NYSE:,DHR) announced that ... will be presenting at the J.P. Morgan Healthcare ... 11:00 a.m. EST. The audio will be,simultaneously webcast ... on http://www.danaher.com for one week., ...
Cached Biology Technology:Model is first to compare performance of 'biosensors' 2Model is first to compare performance of 'biosensors' 3Pharmos Corporation Announces Board and Management Changes 2Pharmos Corporation Announces Board and Management Changes 3
(Date:7/9/2015)... Calif. , July 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... Thursday, July 30, 2015 after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. ... of human interface solutions, today announced a ... first fully hardware encapsulated fingerprint sensor and ... technology is literally off the grid, isolating ... matching within the fingerprint sensor to provide ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. (NASDAQ: ... diagnostics, today announced the launch of a study ... Precision Cancer Monitoring℠ (PCM) technology for predicting response ... or a combination of the novel immunotherapy agents ... a PD-1 inhibitor. The 50-patient study will be ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... fact that they eat a lot and often may ... majority of fungal pathogens, according to research from Albert Einstein College ... the Journal of Infectious Diseases , showed that the elevated ... C in people is too high for the vast majority ...
... 15, 2009 / b3c newswire / - KINAXO ... that they will enter into collaboration. KINAXO will ... identification of novel biomarkers in a clinical trial ... allows annotation and quantification of regulated phosphorylation sites. ...
... Testicular cancer survivors can face an increased risk ... the highly effective treatment they receive, according to a ... Researchers from the Norwegian Radium Hospital at ... problems faced by survivors are higher than generally thought, ...
Cached Biology News:Do 3 meals a day keep fungi away? 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 2KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 3KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification 4Treatment not testicular cancer poses greatest risk to survivors' long-term health 2Treatment not testicular cancer poses greatest risk to survivors' long-term health 3
... DASGIP Overhead Drive for individual and parallel ... flexible agitation of DASGIP vessels, featuring range ... ,Up to 16 overhead drives can ... Cultivation Systems fedbatch-pro® and cellferm-pro® for microbiology ...
... Whatever your Ion Chromatography requirements, IonQuest ... The newly developed conductivity detector has ... drift . In addition to the ... used with other detectors, such as electrochemical, ...
This pump accomodates StemSep ; pump feed columns of the following sizes : 0.3in., 0.5in., 0.6in., and 1.0in.....
...
Biology Products: